Monopar Therapeutics (MNPR) Institutional Ownership and Insiders Activity
Monopar Therapeutics (MNPR) is widely held by institutional investors, with 100 firms reporting positions valued at approximately $520.36M based on SEC Form 13F filings for the quarter ended June 30, 2026.
Janus Henderson Group Plc is the largest disclosed holder, reporting approximately $72.06M in MNPR holdings in its latest filing.
Recent insider activity includes 17 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
100
Total Reported Value
$520.36M
Largest Holder
Janus Henderson Group Plc
Largest Position
$72.06M
Insider Transactions (90d)
17
Latest Filing Quarter
Q2 2026
New Institutional Positions
29
Funds Exiting Positions
17
Top Institutional Owners
View allInvestorReported Balance
- Janus Henderson Group Plc$72.06M
- Ra Capital Management, L.P.$61.78M
- Blackrock, Inc.$32.30M
- Deerfield Management Company, L.P.$29.98M
- Saturn V Capital Management Lp$28.89M
Related MNPR Institutional Insights:
- MNPR 13F Institutional Holders
- MNPR Superinvestors
- MNPR Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- MNPR Insider Trading & SEC Form 4 Activity
- MNPR Articles
- Top Institutional Investor Stock Rankings